Half-Year 2022 Financial and Clinical Trials Update slide image

Half-Year 2022 Financial and Clinical Trials Update

TIB-Molbiol SARS-CoV-2 menu for monitoring new variants Detecting major variants in hours vs a week for sequencing Roche BA.1 & BA.1.1 BA.3 XE BA.2 & BA.2.2 BA.2.12.1 BA.2.75 21K (Omicron) 21M (Omicron) 21L (Omicron) BA.5 XF 20B 21 (Delta 21A (Delta) BA.4 BA.5 is becoming the dominant SARS-CoV-2 variant Delta 41 11
View entire presentation